Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ligand Pharmaceuticals | LGND | Nov 27, 2024 | 122.55 | -1.43 |
Light & Wonder | LNW | Nov 27, 2024 | 97.08 | -0.88 |
Lightbridge | LTBR | Nov 27, 2024 | 5.75 | -0.69 |
LightInTheBox Holding ADR | LITB | Nov 27, 2024 | 1.96 | -3.92 |
LightPath Technologies A | LPTH | Nov 27, 2024 | 1.66 | 0.00 |
Lightspeed Commerce | LSPD | Nov 27, 2024 | 18.77 | +2.85 |
Lightwave Logic | LWLG | Nov 27, 2024 | 2.80 | +2.94 |
Lilium N.V. A | LILM | Nov 27, 2024 | 0.08 | 0.00 |
Limbach | LMB | Nov 27, 2024 | 98.76 | -3.20 |
Limoneira | LMNR | Nov 27, 2024 | 27.62 | -1.00 |
Lincoln Educational Services | LINC | Nov 27, 2024 | 16.49 | +0.18 |
Lincoln Electric | LECO | Nov 27, 2024 | 216.62 | +0.22 |
Lincoln National | LNC | Nov 27, 2024 | 35.45 | +0.25 |
Lincoln National Pref | LNC-D | Nov 27, 2024 | 28.00 | +0.65 |
Lindblad Expeditions | LIND | Nov 27, 2024 | 12.60 | -0.87 |
Linde | LIN | Nov 27, 2024 | 457.12 | +0.11 |
Lindsay | LNN | Nov 27, 2024 | 131.62 | +0.41 |
Lineage | LINE | Nov 27, 2024 | 64.46 | -0.17 |
Lineage Cell Therapeutics | LCTX | Nov 27, 2024 | 0.57 | -5.98 |
Linkage Global A | LGCB | Nov 27, 2024 | 0.23 | +4.77 |
Linkbancorp | LNKB | Nov 27, 2024 | 7.62 | +2.01 |
Lion ADR | LGHL | Nov 27, 2024 | 0.18 | +0.06 |
Lion Electric | LEV | Nov 27, 2024 | 0.20 | -1.18 |
Lionheart Units | CUBWU | Nov 27, 2024 | 10.07 | 0.00 |
Lions Gate Entertainment A | LGF-A | Nov 27, 2024 | 8.38 | +6.35 |
Lions Gate Entertainment B | LGF-B | Nov 27, 2024 | 7.43 | +6.14 |
Lipella Pharmaceuticals | LIPO | Nov 27, 2024 | 2.95 | +5.36 |
Lipocine | LPCN | Nov 27, 2024 | 4.45 | +0.68 |
LiqTech International | LIQT | Nov 27, 2024 | 1.85 | +6.02 |
Liquidia | LQDA | Nov 27, 2024 | 11.62 | +1.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.